These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
2273 related items for PubMed ID: 36159012
1. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma. Deng PZ, Zhao BG, Huang XH, Xu TF, Chen ZJ, Wei QF, Liu XY, Guo YQ, Yuan SG, Liao WJ. World J Gastroenterol; 2022 Aug 21; 28(31):4376-4389. PubMed ID: 36159012 [Abstract] [Full Text] [Related]
2. A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy. Liu Q, Li J, Liu F, Yang W, Ding J, Chen W, Wei Y, Li B, Zheng L. Cancer Imaging; 2020 Nov 16; 20(1):82. PubMed ID: 33198809 [Abstract] [Full Text] [Related]
4. Prediction of early recurrence of hepatocellular carcinoma after liver transplantation based on computed tomography radiomics nomogram. Zhao JW, Shu X, Chen XX, Liu JX, Liu MQ, Ye J, Jiang HJ, Wang GS. Hepatobiliary Pancreat Dis Int; 2022 Dec 16; 21(6):543-550. PubMed ID: 35705443 [Abstract] [Full Text] [Related]
6. A radiomics nomogram for preoperative prediction of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma. Peng J, Zhang J, Zhang Q, Xu Y, Zhou J, Liu L. Diagn Interv Radiol; 2018 Dec 16; 24(3):121-127. PubMed ID: 29770763 [Abstract] [Full Text] [Related]
7. Radiomics and nomogram of magnetic resonance imaging for preoperative prediction of microvascular invasion in small hepatocellular carcinoma. Chen YD, Zhang L, Zhou ZP, Lin B, Jiang ZJ, Tang C, Dang YW, Xia YW, Song B, Long LL. World J Gastroenterol; 2022 Aug 21; 28(31):4399-4416. PubMed ID: 36159011 [Abstract] [Full Text] [Related]
8. 18F-FDG PET/CT-based radiomics nomogram for preoperative prediction of macrotrabecular-massive hepatocellular carcinoma: a two-center study. Hu S, Kang Y, Xie Y, Yang T, Yang Y, Jiao J, Zou Q, Zhang H, Zhang Y. Abdom Radiol (NY); 2023 Feb 21; 48(2):532-542. PubMed ID: 36370179 [Abstract] [Full Text] [Related]
9. Preoperative radiomics nomogram for microvascular invasion prediction in hepatocellular carcinoma using contrast-enhanced CT. Ma X, Wei J, Gu D, Zhu Y, Feng B, Liang M, Wang S, Zhao X, Tian J. Eur Radiol; 2019 Jul 21; 29(7):3595-3605. PubMed ID: 30770969 [Abstract] [Full Text] [Related]
12. Radiomics-based nomogram using CT imaging for noninvasive preoperative prediction of early recurrence in patients with hepatocellular carcinoma. Zhu HB, Zheng ZY, Zhao H, Zhang J, Zhu H, Li YH, Dong ZY, Xiao LS, Kuang JJ, Zhang XL, Liu L. Diagn Interv Radiol; 2020 Sep 21; 26(5):411-419. PubMed ID: 32490826 [Abstract] [Full Text] [Related]
13. A CT-based radiomics nomogram for differentiation of focal nodular hyperplasia from hepatocellular carcinoma in the non-cirrhotic liver. Nie P, Yang G, Guo J, Chen J, Li X, Ji Q, Wu J, Cui J, Xu W. Cancer Imaging; 2020 Feb 24; 20(1):20. PubMed ID: 32093786 [Abstract] [Full Text] [Related]
14. Computed tomography-based radiomics to predict early recurrence of hepatocellular carcinoma post-hepatectomy in patients background on cirrhosis. Qian GX, Xu ZL, Li YH, Lu JL, Bu XY, Wei MT, Jia WD. World J Gastroenterol; 2024 Apr 21; 30(15):2128-2142. PubMed ID: 38681988 [Abstract] [Full Text] [Related]
15. Hepatocellular carcinoma: radiomics nomogram on gadoxetic acid-enhanced MR imaging for early postoperative recurrence prediction. Zhang Z, Jiang H, Chen J, Wei Y, Cao L, Ye Z, Li X, Ma L, Song B. Cancer Imaging; 2019 May 14; 19(1):22. PubMed ID: 31088553 [Abstract] [Full Text] [Related]
16. Prediction early recurrence of hepatocellular carcinoma eligible for curative ablation using a Radiomics nomogram. Yuan C, Wang Z, Gu D, Tian J, Zhao P, Wei J, Yang X, Hao X, Dong D, He N, Sun Y, Gao W, Feng J. Cancer Imaging; 2019 Apr 26; 19(1):21. PubMed ID: 31027510 [Abstract] [Full Text] [Related]
17. Development and Validation of a Contrast-Enhanced CT-Based Radiomics Nomogram for Prediction of Therapeutic Efficacy of Anti-PD-1 Antibodies in Advanced HCC Patients. Yuan G, Song Y, Li Q, Hu X, Zang M, Dai W, Cheng X, Huang W, Yu W, Chen M, Guo Y, Zhang Q, Chen J. Front Immunol; 2020 Apr 26; 11():613946. PubMed ID: 33488622 [Abstract] [Full Text] [Related]
18. Radiomics Signature: A potential biomarker for the prediction of survival in Advanced Hepatocellular Carcinoma. Li L, Kan X, Zhao Y, Liang B, Ye T, Yang L, Zheng C. Int J Med Sci; 2021 Apr 26; 18(11):2276-2284. PubMed ID: 33967603 [Abstract] [Full Text] [Related]
19. Comprehensive radiomics nomogram for predicting survival of patients with combined hepatocellular carcinoma and cholangiocarcinoma. Tang YY, Zhao YN, Zhang T, Chen ZY, Ma XL. World J Gastroenterol; 2021 Nov 07; 27(41):7173-7189. PubMed ID: 34887636 [Abstract] [Full Text] [Related]
20. Development and validation of a comprehensive radiomics nomogram for prognostic prediction of primary hepatic sarcomatoid carcinoma after surgical resection. Tang Y, Zhang T, Zhao Y, Chen Z, Ma X. Int J Med Sci; 2021 Nov 07; 18(7):1711-1720. PubMed ID: 33746587 [Abstract] [Full Text] [Related] Page: [Next] [New Search]